What is OS Therapies's capex?

OS Therapies (OSTX) reported capex of $316.42K in Q2 2025.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

ImmunomeIMNM

$3M-18.1%

ImmunityBio, Inc.IBRX

$1.78M+58.4%

Arcus BiosciencesRCUS

$0-100%

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Operating cash flow-$4.6M-32.6%

Free cash flow-$3.7M—

Market cap$84.62M+66.4%

Enterprise value$103.7M—

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireProductiveAssets.

The official record: OS Therapies’s 10-Q, filed August 18, 2025, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is OS Therapies's capex?: OS Therapies (OSTX) reported capex of $316.42K in Q2 2025.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.